The critical roles that PAP activity plays in humans and mice are typified by assorted abnormalities (e.g., lipodystrophy, insulin resistance, peripheral neuropathy, rhabdomyolysis) that result from the loss of the lipin 1 enzyme (104, 105, 106, 107, 108, 109). The gene discussed is LPIN1; the disease is peripheral neuropathy.